Norman Noble adds engineering design services for medical implants

Norman Noble, Inc., Highland Heights, Ohio, announced in February 2026 the addition of engineering design services to its medical-implant manufacturing portfolio. The new offering supports customers developing implantable devices that require advanced laser machining of nitinol, cobalt-chromium, titanium, and other high-performance alloys, and lets device makers partner with Norman Noble at the earliest stages of product development.

Through the engineering design service, Norman Noble’s team works with customers on drawing specifications, design for manufacturability, prototyping strategy, and process development with the goal of moving from concept to validated prototype faster than is typical with sequential outsourcing. The capability builds on the company’s existing offerings in laser machining, athermal Noble STEALTH laser processing, Noble SynchroFlash, and Noble DryEPolish surface finishing — all of which are already used across the cardiovascular, structural heart, neurovascular, and orthopedic implant markets.

By adding upfront design support, Norman Noble strengthens its position as a contract development and manufacturing organization (CDMO) for complex implantable devices. The expansion reflects increasing customer demand for integrated end-to-end partners that can carry a device from early concept through validated production, particularly for nitinol implants where design choices and manufacturing methods are tightly coupled.

Norman Noble, Inc. is a privately held precision contract manufacturer headquartered in Highland Heights, Ohio. The company specializes in laser machining and finishing of nitinol and other implant-grade alloys, and supports the development and manufacture of finished medical implants for global medical device customers.

Read further here

FDA approves JenaValve Trilogy transcatheter heart valve for aortic regurgitation

JenaValve Technology, Irvine, California, received U.S. Food and Drug Administration approval on March 23, 2026 for the Trilogy Heart Valve System for the treatment of symptomatic severe aortic regurgitation in patients deemed at high or greater risk for surgical aortic valve replacement. Trilogy is the first and only transcatheter heart valve approved in the United States for aortic regurgitation, addressing a long-standing unmet need in structural heart medicine.

The Trilogy device is a self-expanding, transcatheter aortic valve implant built on a low-profile nitinol frame with porcine pericardial tissue leaflets. The device’s locator architecture is designed to engage the native aortic leaflets to provide secure anchoring in regurgitant anatomy that lacks the calcified landing zone typically used for transcatheter valves indicated for aortic stenosis.

The approval is supported by the ALIGN-AR pivotal trial, which evaluated Trilogy in patients with symptomatic severe aortic regurgitation at prohibitive or high surgical risk. The trial demonstrated meaningful reductions in regurgitation severity at one year alongside acceptable safety endpoints, providing the first prospective evidence base for a dedicated AR transcatheter device in the United States.

JenaValve Technology develops transcatheter heart valve systems for the treatment of aortic regurgitation and aortic stenosis. The company is privately held and headquartered in Irvine, California.

Read further here

Fort Wayne Metals receives Medtronic 2025 Supplier Innovation Excellence Award

Fort Wayne Metals, Fort Wayne, Indiana, received Medtronic’s 2025 Supplier Innovation Excellence Award for its nitinol melt program, which Medtronic recognized for strengthening global supply chain resilience and supporting the advancement of life-improving medical technologies.

Fort Wayne Metals is a fully integrated nitinol supplier, controlling every step of the manufacturing process from ingot melting through custom finishing of wires, tubes, and components. The company began working with nitinol in 1991 and established a dedicated melt facility in 2012. Between 2022 and 2024, production of melted nitinol for medical applications doubled, and a second vacuum arc remelting (VAR) furnace brought online in early 2025 positions the company to double output again. Melted nitinol now represents 74 percent of all nitinol products the company sells.

“Our goal is to enable our customers to develop their innovations, from nitinol melt to custom finishing of products,” said Scott Glaze, President and CEO of Fort Wayne Metals. The award reflects the company’s role as a critical upstream supplier to medical device manufacturers developing stents, guidewires, and implantable components that rely on nitinol’s unique superelastic and shape memory properties.

Fort Wayne Metals employs more than 2,000 people across its Fort Wayne, Indiana headquarters and facilities in Columbia City, Indiana, and Galway, Ireland.

[Read further here](https://www.medicaldesignandoutsourcing.com/medtronic-nitinol-supplier-fort-wayne-metals/)

Dynalloy transfers Flexinol actuator wire technology to insulin pump leader

Dynalloy Inc., Irvine, California, announced the transfer of its Flexinol actuator wire technology, equipment, personnel, and know-how to support vertical integration at one of the world’s largest providers of insulin pump delivery products. The agreement also includes exclusivity for direct-to-human drug delivery applications.

Flexinol actuator wires are made of nickel-titanium shape memory alloy and contract when electrically heated, functioning as compact, silent, lightweight actuators ideally suited for the precise mechanisms required in miniaturized medical devices. The technology transfer enables the insulin pump manufacturer to integrate advanced SMA actuator capabilities directly into its production operations.

In response to the transfer, Dynalloy has relocated to new state-of-the-art facilities to support increased Flexinol actuator wire manufacturing and related value-added products and sub-assemblies for its broader customer base spanning automotive, consumer electronics, aerospace, and industrial automation applications.

[www.dynalloy.com](https://www.dynalloy.com)

Integer to showcase neuromodulation innovations and fast-charge battery at NANS 2026

nteger Holdings Corporation, Plano, Texas, showcased its latest advancements in neuromodulation and next-generation miniaturized active implantable medical devices at the North American Neuromodulation Society Annual Meeting in Las Vegas, January 22-25, 2026.

The company highlighted the Xcellion Gen 3 Fast Charge lithium ion battery, which delivers best-in-class runtime and can recharge in as little as 30 minutes. Integer also demonstrated end-to-end contract development and manufacturing capabilities spanning high-performance batteries, fully integrated implantable pulse generators, and lead systems designed to accelerate development timelines and reduce risk for device companies bringing novel therapies to market.

“Miniaturization is transforming the future of implantable technologies, and we’re proud to partner with customers to make that future a reality,” said Jim Stephens, President of Cardiac Rhythm Management & Neuromodulation at Integer.

Integer Holdings is among the world’s largest medical device contract development and manufacturing organizations, serving cardiac rhythm management, neuromodulation, and cardiovascular markets. Its brands include Greatbatch Medical and Lake Region Medical.

[www.integer.net](https://www.integer.net)

Ilika completes first commercial Stereax electrode delivery to Cirtec Medical

Cirtec Medical, Brooklyn Park, Minnesota, has received the first commercial batch of Stereax solid-state battery electrodes from Ilika, Southampton, United Kingdom, for Stereax M300 production. The delivery fulfills the first revenue-generating order under a commercial supply arrangement initiated in January 2026.

The electrodes will support Stereax M300 batteries used in validation and customer sampling across multiple active implantable medical device categories, including implanted sensors, neurostimulators, orthopedic implants, orthodontic wearables, and ophthalmology devices. The Stereax M300 is an ultra-thin, millimeter-scale, rechargeable solid-state battery containing no liquid or polymer components, designed specifically for implantable applications.

“Our close technical cooperation with Ilika has developed into an effective operational partnership, ensuring customers receive the highest quality product for device integration,” said Shawn Martin, Vice President at Cirtec Medical.

Cathode manufacturing remains at Ilika’s UK facility as the most complex production step, while primary battery manufacturing occurs at Cirtec’s facility in Lowell, Massachusetts. The milestone marks Ilika’s transition from technology development to commercial supply in the medical device battery market.

[www.cirtecmed.com](https://www.cirtecmed.com)

Smith+Nephew signs exclusive US distribution agreement with RMR Ortho for nitinol fixation system

Smith+Nephew, Watford, United Kingdom, announced an exclusive US distribution agreement with RMR Ortho to add the A’TOMIC Nitinol Fixation System to its Trauma, Foot & Ankle, and Hand & Wrist portfolio.

The A’TOMIC system leverages proprietary manufacturing methods and the unique properties of nitinol to provide compressive fixation implants featuring a wide bridge with barbed, round legs that match drill holes. The system is engineered to achieve stability of fusion, fracture, and osteotomy sites through high strength and active compression, designed to improve implant integrity and patient comfort.

“This partnership strengthens Smith+Nephew’s fixation portfolio by adding a dynamic compression fixation solution that complements our existing technologies,” said Scott Gunn, Vice President of U.S. Marketing, Trauma, Extremities, and Shoulder at Smith+Nephew. The agreement expands the company’s ability to participate in high-frequency fracture and arthrodesis procedures while leveraging established Extremities and Trauma sales channels.

“Partnering with Smith+Nephew represents an important step forward as we continue to expand access to the A’TOMIC Nitinol Fixation System across key U.S. territories,” said Joe Ritz, CEO of RMR Ortho.

Smith+Nephew is a global medical technology company operating in more than 100 countries with approximately 18,000 employees.

[www.smith-nephew.com](https://www.smith-nephew.com)

Norman Noble to Open Rapid Prototype Facility in Irvine, California

Norman Noble, Highland Heights, Ohio, announced plans to open a new rapid prototype facility in Irvine, California. The West Coast location will expand the company’s ability to support early-stage development and rapid prototyping while strengthening collaboration with medical device OEMs across the Western U.S.

“Opening a rapid prototype facility in Irvine is a strategic investment in how we support our customers throughout the product lifecycle,” said Dan Stefano, chief executive officer. “By expanding our R&D prototyping footprint, we’re enabling easier face-to-face collaboration, faster iteration, and more manufacturable designs.”

Southern California is one of the largest medical device hubs in the country, with a high concentration of both established OEMs and startup innovators. The Irvine facility will feature advanced laser cutting, shape setting, and electropolishing capabilities to manufacture prototype design iterations in a matter of days.

The new location complements Norman Noble’s existing prototype and production facilities in Ohio, Florida, and Ontario, Canada. Established 80 years ago, Norman Noble remains a family-owned company offering advanced processes for ultra-precision micromachining of medical implants. The company is known for its ability to produce nitinol-based implants and achieve sub-miniature precision beyond the reach of most manufacturers.

Read further here

Tokamak Energy and Furukawa Electric Group to build fusion magnet manufacturing base in Japan

Tokamak Energy and Furukawa Electric Group, Tokyo, Japan announced that they will establish a joint operational base in Japan to manufacture high-temperature superconducting magnets critical for fusion power plants. The facility will support the Fusion Advanced Superconducting Tokamak (FAST) development project, which aims to demonstrate electricity generation from fusion by the 2030s, under a private-sector collaboration led by Starlight Engine Ltd.

The partnership leverages Tokamak Energy’s network of government, commercial, scientific and academic collaborators in Japan alongside Furukawa Electric’s expertise in REBCO-coated HTS tape production through its SuperPower subsidiary. Beyond fusion, the companies plan to explore applications of their HTS magnet technology in sectors such as data-centre cooling, zero-emission electric motors, power generation and propulsion systems for land, air, water and space.

Warrick Matthews, chief executive of Tokamak Energy, explained that scaling up magnet manufacturing will be pivotal to translating the promise of clean, limitless fusion into commercial reality and will unlock new performance levels across multiple industries. Hideya Moridaira, president of Furukawa Electric Group, added that deepening the collaboration reflects Furukawa’s long-standing commitment to superconducting research and its ambition to support energy and healthcare innovations.

The agreement follows a UK-Japan government fusion partnership announced during ministerial talks in London, underscoring both nations’ strategic push for sustainable, safe and abundant fusion energy.

Read further here.

Chance discovery improves stability of bioelectronic material used in medical implants, computing and biosensors

A chance discovery by scientists from Rice University, University of Cambridge, and Stanford University has streamlined the production of PEDOT:PSS, a material widely used in medical research and computing. For over two decades, a chemical crosslinker was used to stabilize this conductive polymer in water. However, while experimenting with patterning techniques for biomedical optics, Stanford doctoral student Siddharth Doshi, collaborating with Rice’s Scott Keene, found that heating the material at a higher temperature without the crosslinker resulted in a stable sample, eliminating the need for the crosslinker.

“It was more of a serendipitous discovery because Siddharth was trying out processes very different to the standard recipe, but the samples still turned out fine,” Keene said. “We were like, ‘Wait! Really?’ This prompted us to look into why and how this worked.”

What Keene and his team found was that heating PEDOT:PSS beyond the usual threshold not only makes it stable without needing any crosslinker, but it also creates higher quality devices. This method could make bioelectronic devices easier and more reliable to manufacture with potential applications in neural implants, biosensors and next-generation computing systems.

PEDOT:PSS is a blend of two polymers: one that conducts electronic charge and does not dissolve in water and another that conducts ionic charge and is water-soluble. Because it conducts both types of charges, PEDOT:PSS bridges the gap between living tissue and technology.

“It allows you to essentially talk the language of the brain,” said Keene, who researches advanced materials for smaller, high-resolution electrodes capable of both recording and stimulating neural activity with precision.

The human nervous system relies on ions—charged particles like sodium and potassium—to transmit signals, while electronic devices work with electrons. A material that can handle both is crucial for neural implants and other bioelectronic devices that need to translate biological activity into readable data and send signals without damaging sensitive tissue.

In contrast, the higher heat stabilizes PEDOT:PSS by causing a phase change in the material. When heated beyond a certain temperature, the water-insoluble polymer reorganizes internally, pushing the water-soluble components to the surface, where they can be washed away. What remains is a thinner, purer and more stable conducting film.

“This method pretty much simplifies a lot of these problems that people have working with PEDOT:PSS,” Keene said. “It also essentially eliminates a potentially toxic chemical.”

Margaux Forner, a doctoral student at Cambridge who is a first author on the paper along with Doshi, said that heat-treated bioelectronic devices such as transistors, spinal cord stimulators and electrocorticography arrays — implanted grids or strips of neuroelectrodes used to record brain activity — were easier to fabricate, more reliable and equally high performing to those fabricated using the crosslinker.

“The devices made from heat-treated PEDOT:PSS proved to be robust in chronic in vivo experiments, maintaining stability for over 20 days postimplantation,” Forner said. “Notably, the film maintained excellent electrical performance when stretched, highlighting its potential for resilient bioelectronic devices both inside and outside the body.”

The finding may help explain why previous efforts to use PEDOT:PSS in long-term neural implants, including those by Neuralink, ran into stability issues. By making PEDOT:PSS more reliable, this discovery could help advance neurotechnology, including implants to restore movement after spinal cord injuries and interfaces that link the brain to external devices.

Beyond simplifying fabrication, the team found a way to pattern PEDOT:PSS into microscopic 3D structures — a breakthrough that could further improve bioelectronic devices. Using a high-precision femtosecond laser, the researchers can selectively heat sections of the material, creating custom textures that enhance how cells interact with the devices.

By eliminating the crosslinker, the research findings not only streamline the PEDOT:PSS fabrication process but also improve its performance. The new method produces a material with three times higher electrical conductivity and more consistent stability between batches — key advantages for medical applications.

The crosslinker worked by chemically bonding the two types of polymer strands in PEDOT:PSS together, creating an interconnected mesh. However, it still left some of the water-soluble strands exposed — a likely cause for the stability issues. Moreover, the crosslinker introduced variability and potential toxicity in the material.

This technique could be used to design neural interfaces that encourage better integration with surrounding tissue, improving signal quality and longevity.

Keene had also previously researched PEDOT:PSS in the context of neuromorphic memory devices used to accelerate artificial intelligence algorithms. Neuromorphic memory is a type or artificial memory that mimics how the brain retains information.

“It basically emulates the synaptic plasticity of your brain,” Keene said. “We can modify the connection between two terminals by controlling how conductive this material is; this is very similar to how your brain learns by strengthening or weakening synaptic connections between individual neurons.”

By unseating a long-standing assumption, the research not only made PEDOT:PSS easier to work with but also more powerful — a shift that could accelerate the development of safer, more effective neural implants and bioelectronic systems.

For more information: Rice University

Image: Implantable electrocorticography device (left) made using the heat treatment method (Photo courtesy of Margaux Forner); Rice University logo (right) patterned into PEDOT:PSS using a femtosecond laser

Integer completes sale of Electrochem business, focusing on medical technology

Integer Holdings Corp., Plano, Texas, announced that it has finalized the divestiture of its Electrochem business to Ultralife Corp. for $50 million in cash. The sale marks Integer’s transition to a pure-play medical technology company, allowing it to focus exclusively on the development and manufacturing of medical devices.

The proceeds from the transaction will be used to reduce the company’s outstanding debt. Joseph Dziedzic, president and chief executive officer at Integer, emphasized that this move positions the company to allocate resources toward high-growth opportunities within the medical technology sector. He also expressed gratitude to the Electrochem team for their contributions over the years and confidence in their future under Ultralife’s ownership.

The divestiture aligns with Integer’s strategic goal to concentrate on advancing its role as a leading contract development and manufacturing organization for the medical device industry.

Read further here 

Fort Wayne metals introduces customizable tube for medical applications

Fort Wayne Metals, Ind., announced that it has developed HHS tube, an innovative product with a highly customizable structure designed to meet the specific functional requirements of various medical applications. This advancement is intended to address the increasing demand for versatile and reliable metal tubing in devices such as endovascular tools, minimally invasive instruments, neurological components, and urological devices.

HHS tube stands out from conventional tubing due to its ability to be tailored to precise specifications. The product can be manufactured in single, two, or three-layer stranded configurations, with customization options that include inner and outer diameters, wire count and size, pitch direction, and overall length. Inner diameters range from 80 µm to 2.2 mm, while outer diameters span 0.13 mm to 4 mm, allowing it to meet a wide variety of customer requirements.

The versatility of HHS tube makes it suitable for a broad range of applications. For example, neurological stimulation devices require thin, flexible filaments to navigate small and complex areas, while vascular tools demand elongation and compressive strength to deliver instruments to targeted sites. Endoscopy devices benefit from the tube’s ability to provide rotational control in navigating the body. Each configuration of the HHS tube is engineered to meet the specific functional demands of the application.

Fort Wayne Metals also offers custom finishing options to streamline the supply chain for its customers. These include custom fittings, terminations, Nitinol coatings, and specialized parts to support seamless integration into final medical device assemblies. This capability underscores the company’s commitment to meeting the evolving needs of the medical sector.

Read further here 

Furukuwa opens new laser processing laboratory in Aichi prefecture to advance industrial solutions

Furukawa Electric Co. Ltd., Tokyo, Japan, and Nichia Corp., Tokushima, Japan, announced that they have jointly opened the Cutting-Edge Laser Processing Solution Laboratory (CELL) in Kariya City, Aichi Prefecture. Located in a key hub of the automotive industry, the new facility is designed to accelerate the development of laser processing technologies and provide innovative solutions to industrial challenges.

The laboratory is equipped with Furukawa Electric’s advanced industrial lasers, including the newly developed 5kW blue laser (BR5000), which delivers world-leading brightness through optical fiber. Plans are in place to install the full range of Furukawa Electric’s industrial lasers, including the BRACE Series of Blue-IR hybrid lasers, enabling the lab to meet diverse customer requirements and expedite process testing and evaluations.

CELL is a collaborative effort between Furukawa Electric and Nichia, facilitating activities that span laser processing and light source development. This partnership will enable the two companies to propose next-generation laser solutions tailored to specific customer needs, with a particular focus on addressing the demands of copper processing for the electrification of mobility.

Both companies are committed to advancing laser technology and supporting the development of innovative production methods, contributing to the evolution of the automotive and related industries.

Read further here: 

Tin toughens bioimplant titanium alloys through cocktail effect

Beta (β)-type titanium (Ti) alloys are renowned for their strength, formability, and resistance to harsh environments, making them ideal for implants and prosthetics. However, under certain conditions, a brittle omega phase can form, making the material prone to breaking. While it is known that adding tin (Sn) negates this, and makes β-type Ti alloys stronger, the exact mechanics behind this continued to puzzle scientists. That is until researchers recently discovered a metallurgical cocktail effect to explain it.

Continue reading

Confluent announces significant investment in ATI nitinol melt expansion

Confluent Medical Technologies (Confluent) announced that it has partnered with ATI to invest more than $50 million over the next several years in ATI’s Nitinol melt and materials conversion infrastructure. With this significant investment, which will more than triple ATI’s melt capacity for medical Nitinol, Confluent will become ATI’s fulfillment partner and provide a suite of value-added services and order fulfillment for ATI medical Nitinol mill product.

“The growth in Neurovascular, Electrophysiology, Structural Heart, Peripheral Vascular, and Orthopedic device markets is driving an 18% growth rate (CAGR) in Nitinol demand. Given the substantial equipment and infrastructural cost needed to increase supply chain capacity, the industry has struggled to support this growth,” stated Dean Schauer, CEO and President of Confluent. “Our investment in this critical infrastructure will provide the necessary mid-term and long-term melt and conversion capacity necessary to meet and support Nitinol material demand. As the most trusted supply partner for our OEM customers, Confluent is pleased to be making this investment in creating a reliable supply chain so that OEMs can continue providing life-saving devices in these specialized markets.”

“ATI is honored to partner with Confluent in producing what is literally a life-saving material,” said Rob Foster, President of ATI’s Specialty Alloys & Components business. “We appreciate the value Confluent places on our expertise and capabilities as the industry leader in Nitinol production. Confluent’s investment in ATI’s growth will ensure the stable supply of Nitinol the industry needs for growth.” The expansion at ATI’s Millersburg, Oregon facility is expected to come online in 2027.

With these expanded capabilities and capacity investments, Confluent will continue to provide customers with the most reliable supply chain delivering the broadest level of Medical Nitinol services in mill products, hollows, tubes, wires, and components.

For more information: Confluent

Norman Noble develops higher power system for Nitinol implants

Norman Noble, Highland Heights, Ohio, has developed a high power system to provide the cleanest cut with no HAZ (Heat Affected Zone).

Norman Noble’s vice president of manufacturing, Dan Stefano said, “We are excited to announce the release of our Stealth HP Laser Cutting technology. This state-of-the-art laser cutting process provides for cutting thicker wall Nitinol medical devices HAZ-free while reducing the need for costly secondary operations. This technology, coupled with our fully automated/validated processes, continues to position Norman Noble as a leading contract manufacturer for the production of medical devices and implants.”

Noble STEALTH HP is an ultrashort pulse laser that reduces or eliminates costly deburring and post-processing steps because it can cut with no heat affected zone. These elements increase quality and yield of medical devices. Athermal lasers enable the machining of next generation vascular and orthopedic implants that otherwise would be impossible to produce.

read further here. 

Scientists 3D print a complex robotic hand with bones, tendons, and ligaments

Scientists have tried to use additive manufacturing—better known as 3D printing—to recreate complex structures from hands to hearts. However, the technology stumbles when integrating multiple materials into one printing process. 3D printing a robotic hand, for example, requires multiple printers—one to make the skeleton, another for soft tissue materials—and the assembly of parts. These multiple steps increase manufacturing time and complexity.

Scientists have long sought to combine different materials into a single 3D printing process. A team from the soft robotics lab at ETH Zurich has found a way.

The team equipped a 3D inkjet printer—which is based on the same technology in normal office printers—with machine vision, allowing it to rapidly adapt to different materials. The approach, called vision-controlled jetting, continuously gathers information about a structure’s shape during printing to fine-tune how it prints the next layer, regardless of the type of material.

In a test, the team 3D printed a synthetic hand in one go. Complete with skeleton, ligaments, and tendons, the hand can grasp different objects when it “feels” pressure at its fingertips.

They also 3D printed a structure like a human heart, complete with chambers, one-way valves, and the ability to pump fluid at a rate roughly 40 percent of an adult human’s heart.

Recreating a structure using conventional methods is tedious and error-prone. Engineers cast a mold to form the desired shape—say, the skeleton of a hand—then combine the initial structure with other materials.

It’s a mind-numbing process requiring careful calibration. Like installing a cabinet door, any errors leave it lopsided. For something as complex as a robot hand, the results can be rather Frankenstein.

Traditional methods also make it difficult to incorporate materials with different properties, and they tend to lack the fine details required in something as complex as a synthetic hand. All these limitations kneecap what a robotic hand—and other functional structures—can do.

Then 3D inkjet printing came along. Common versions of these printers squeeze a liquid resin material through hundreds of thousands of individually controlled nozzles—like an office printer printing a photo at high resolution. Once a layer is printed, a UV light “sets” the resin, turning it from liquid to solid. Then the printer gets to work on the next layer. In this way, the printer builds a 3D object, layer by layer, at the microscopic level.

Although incredibly quick and precise, the technology has its problems. It isn’t great at binding different materials together, for instance. To 3D print a functional robot, engineers must either print parts with multiple printers and then assemble them after, or they can print an initial structure, cast around the part, and add additional types of materials with desired properties.

One main drawback is the thickness of each layer isn’t always the same. Differences in the speed of “ink,” interference between nozzles, and shrinkage during the “setting” process can all cause tiny differences. But these inconsistencies add up with more layers, resulting in malfunctioning objects and printing failure.

Engineers tackle this problem by adding a blade or roller. Like flattening newly laid concrete during roadwork, this step levels each layer before the next one starts. The solution, unfortunately, comes with other headaches. Because the rollers are only compatible with some materials—others gunk up the scraper—they limit the range of materials that can be used.

What if we don’t need this step at all?

The team’s solution is machine vision. Rather than scraping away extra material, scanning each layer as it’s printing helps the system detect and compensate for small mistakes in real-time.

The machine vision system uses four cameras and two lasers to scan the entire printing surface at microscopic resolution.

This process helps the printer self-correct, explained the team. By understanding where there’s too much or too little material, the printer can change the amount of ink deposited in the next layer, essentially filling previous “potholes.” The result is a powerful 3D printing system in which extra material doesn’t need to be scraped off.

This isn’t the first time machine vision has been used in 3D printers. But the new system can scan 660 times faster than older ones, and it can analyze the growing structure’s physical shape in less than a second, wrote Kong. This allows the 3D printer to access a much larger library of materials, including substances that support complex structures during printing but are removed later.

As a test, the team printed a synthetic hand with two types of materials: a rigid, load-bearing material to act as a skeleton and a soft bendable material to make tendons and ligaments. They printed channels throughout the hand to control its movement with air pressure and at the same time integrated a membrane to sense touch—essentially, the fingertips.

They hooked the hand to external electrical components and integrated it into a little walking robot. Thanks to its pressure-sensing fingertips, it could pick up different objects—a pen or an empty plastic water bottle.

The system also printed a human-like heart structure with multiple chambers. When pressurizing the synthetic heart, it pumped fluids like its biological counterpart.

Everything was printed in one go.

For more information: Nature

Enovis recognized as one of America’s Greatest Workplaces 2023 by Newsweek

Enovis Corp., Wilmington, Del., has announced today that it has been recognized as one of America’s Greatest Workplaces 2023 by Newsweek.

Newsweek partnered with Plant-A Insights Group, a market-data research firm, to identify America’s Greatest Workplaces by conducting a large-scale employer study based on over 389,000 company reviews in the United States. “Enovis is proud to provide a positive work environment where employees can thrive through our culture of continuous improvement and a commitment to improving patient outcomes,” said Matt Trerotola, chief executive officer of Enovis. “This award recognizes our passionate drive to create better together every day as we develop the next generation of medical technology, and we are honored to be named one of the greatest workplaces in America.”

Already recognized as one of America’s Greatest Workplaces for Diversity, Enovis places significant importance on building and sustaining a diverse, equitable and inclusive work environment while fostering a collaborative culture that empowers its team of extraordinary talent to reach their full potential.

 

Read further here.

Shape memory alloy reinforcement for strengthening of RCC structures

Raisoni College of Engineering, India, has published a critical review of significant performance and safety issues that arise from the deterioration of reinforced concrete (RC) structural components brought on by ageing processes and high stress occurrences. 

Shape memory alloys (SMAs), one of the options for restoring such components, have special qualities including recovering inelastic strain when unloaded (super elasticity) or heated (shape memory effect, SME). To lessen permanent deformations into RC constructions, super elasticity and SME of SMA bars can be used. The stiffness and strength of RC structures can also be improved by the addition of SMAs, allowing them to withstand loads of high intensities with minimal damage. 

Despite the wide range of studies done on the applications of SMAs in structures, a comprehensive analysis of the present state, key results, potential drawbacks, and future contemplation of SMA bars for the reinforcement of RC structures is lacking in the literature. 

Read further here

QMD precision components business now part of Cirtec Medical

Cirtec Medical Corp., Lowell, Mass., has acquired QMD Precision Components, a business that specializes in the development and manufacturing of silicone, polyisoprene, and other custom elastomeric components, tubing, and subassemblies. 

Cirtec is a strategic outsourcing partner of complex medical devices, including minimally invasive and active implantable devices. The acquisition will enable Cirtec to provide customers with advanced expertise in medical silicone molding and extrusion. The integration of Precision Components within the Cirtec brand will offer comprehensive, integrated solutions based on decades of silicone experience. The acquisition will also strengthen Cirtec’s platform for growth in existing markets such as active implantables, interventional, and minimally invasive surgical devices. Precision Components consists of Centers of Excellence in Sturtevant, Wisconsin, and Rock Hill, South Carolina, and engineering and manufacturing capabilities will remain at the facilities, along with current leadership.

Read further here. 

 

Nupress and SPEE3D partnership brings patented cold spray technology to Australian manufacturers

SPEE3D, Australia, announced its WarpSPEE3D printer will be hosted at Nupress headquarters in Australia. Meaning local Australian manufacturers and businesses will be able to access the machine through a subscription without having to lease or purchase it.

This unique subscription model will provide Nupress’s existing clients in the mining, building, aerospace, defense, and medical industries, and other Australian manufacturers’ access to SPEE3D’s patented cold-spray technology. It will provide them the opportunity to source parts locally and quickly from a selection of 12 different metals.

Nupress is a leading manufacturer of precision machined components and assemblies with over 50 years of expertise. Together with SPEE3D, the game-changing subscription service will enable Nupress clients and other Australian manufactures to produce parts at the time of need, rather than waiting weeks or months via other supply chains. Because metal parts can now be sourced locally, this will help manufacturing companies improve their operations and reduce costs – many of which have been impacted negatively due to ongoing global supply chain issues. The subscription model offers one to six slots, each delivering 25 hours per month of printing for 12 months.

“Democratizing access to SPEE3D’s WarpSPEED printer will help solve real-world problems around broken supply chains, manufacturing challenges, and massive delays for some of the world’s most significant industries. Local Australian companies can now access our technology thanks to Nupress, enabling smaller production runs, prototyping needs, material developments, and other advanced manufacturing capabilities,” said Steven Camilleri, Co-Founder, and CTO of SPEE3D.

 

Image – WarpSPEE3D, the technology that will be available at Nupress on a subscription-based service for local Australian organizations.

 

For more information:

Nupress

https://www.nupress.com.au/

 

SPEE3D

https://www.spee3d.com/